Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. Nordlund JJ, Grimes PE, Ortonne JP (2006) The safety of hydroquinone. J Eur Acad Dermatol Venereol 20:781–787. https://doi.org/10.1111/j.1468-3083.2006.01670.x
2. US Food and Drug Administration (2022) FDA works to protect consumers from potentially harmful OTC skin lightening products. https://www.fda.gov/drugs/drug-safety-and-availability/fda-works-protect-consumers-potentially-harmful-otc-skin-lightening-products. Accessed 31 July 2023
3. Ko D, Wang RF, Ozog D, Lim HW, Mohammad TF (2023) Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation. J Am Acad Dermatol 88:291–320. https://doi.org/10.1016/j.jaad.2021.12.065
4. Fabian IM, Sinnathamby ES, Flanagan CJ, Lindberg A, Tynes B, Kelkar RA, Varrassi G, Ahmadzadeh S, Shekoohi S, Kaye AD (2023) Topical hydroquinone for Hyperpigmentation. Narrative Rev Cureus 15:e48840. https://doi.org/10.7759/cureus.48840
5. Lazar M, De La Garza H, Vashi NA (2023) Exogenous ochronosis: characterizing a rare disorder in skin of Color. J Clin Med 12:4341
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献